Latest Advances

  • Journal: Molecules (Basel, Switzerland)
  • Published —
CD47 in the Brain and Neurodegeneration: An Update on the Role in Neuroinflammatory Pathways.
  • Condition: Multiple Myeloma (MM)
  • Journal: Current oncology (Toronto, Ont.)
  • Treatment Used: Disulfiram (DSF)
  • Number of Patients: 0
  • Published —
This article discusses the potential use of disulfiram (DSF) for the treatment of patients with multiple myeloma (MM).
  • Condition: Immunoglobulin Light-Chain Amyloidosis (AL)
  • Journal: The New England journal of medicine
  • Treatment Used: Daratumumab
  • Number of Patients: 388
  • Published —
This study evaluated the outcomes of daratumumab in the treatment of patients with immunoglobulin light-chain amyloidosis (protein disorder; AL).
  • Condition: Solid Tumors and Multiple Myeloma with Bone Metastasis
  • Journal: Journal of orthopaedic surgery and research
  • Treatment Used: Denosumab vs. Zoledronic Acid
  • Number of Patients: 7201
  • Published —
This study compared the safety and effectiveness of denosumab versus zoledronic acid for the treated of patients with advanced cancer with bone metastasis.
  • Journal: Blood advances
  • Published —
Direct P70S6K1 inhibition to replace dexamethasone in synergistic combination with MCL-1 inhibition in multiple myeloma.
  • Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
  • Published —
Taking therapeutic apheresis services to patients in South Africa: An eight year review of SANBS mobile therapeutic apheresis service, 2013-2020.
  • Journal: BioMed research international
  • Published —
The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma.
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Published —
Early Diagnosis of One Multiple Myeloma Patient with Cold Agglutinin Syndrome as the Initial Presentation.
  • Condition: Relapsed Multiple Myeloma
  • Journal: Lancet (London, England)
  • Treatment Used: Isatuximab, Carfilzomib, and Dexamethasone
  • Number of Patients: 302
  • Published —
This study compared the effectiveness of isatuximab plus carfilzomib-dexamethasone versus carfilzomib-dexamethasone in patients with relapsed multiple myeloma.
  • Condition: Immunoglobulin Light Chain (AL) Amyloidosis
  • Journal: Mayo Clinic proceedings
  • Treatment Used: Anti-Plasma Cell Therapies and Supportive Care
  • Number of Patients: 0
  • Published —
This article discusses the treatment of patients with immunoglobulin light chain (AL) amyloidosis (plasma cell disorder).
  • Journal: The Lancet. Oncology
  • Published —
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial.
  • Journal: The Lancet. Haematology
  • Published —
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial.
Showing 1-12 of 454